|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 22, 2017 ) The musculoskeletal system drugs market covers medications used in the treatment of musculoskeletal diseases such as arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus, and other musculoskeletal diseases. Some of the major drugs in the market include Humira, Remicade, Brineura, Tymlos (abaloparatide), and Enbrel.
For more information about this report at http://www.reportsweb.com/musculoskeletal-disorders-drugs-market-global-report-2017
The global musculoskeletal disorders drugs market was estimated to be around $121 billion as of 2016. The musculoskeletal disorders drugs market made up around 11% of the overall pharmaceuticals market in 2016. The musculoskeletal disorders drugs market was the fourth largest market in the global pharmaceutical market in 2016.
New Product Approvals
The product approvals of new musculoskeletal drugs by regulatory bodies is a significant positive trend being witnessed by the market in recent years. For instance, in April 2017, BioMarin received FDA approval for its Brineura (cerliponase alfa) drug that is used for the treatment of late infantile neuronal ceroid lipofuscinosis type 2. In May 2017, Sanofi received FDA approval for its Kevzara drug that is used in the treatment of active rheumatoid arthritis.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890207/sample
Table of Content
1. Musculoskeletal Disorders Drugs Market Characteristics
2. Musculoskeletal Disorders Drugs Market Size And Growth
3. Pestle Analysis
4. Musculoskeletal Disorders Drugs Market Customer Information
5. Musculoskeletal Disorders Drugs Market Segmentation
6. Musculoskeletal Disorders Drugs Market Regional And Country Analysis
7. Global Musculoskeletal Disorders Drugs Market Comparison With Macro Economic Factors
8. Musculoskeletal Disorders Drugs Market Comparison With Macro Economic Factors Across Countries
9. Musculoskeletal Disorders Drugs Market Comparison With Industry Metrics
10. Asia-Pacific Musculoskeletal Disorders Drugs Market
11. Western Europe Musculoskeletal Disorders Drugs Market
12. Eastern Europe Musculoskeletal Disorders Drugs Market
13. North America Musculoskeletal Disorders Drugs Market
14. South America Musculoskeletal Disorders Drugs Market
15. Middle East Musculoskeletal Disorders Drugs Market
16. Africa Musculoskeletal Disorders Drugs Market
17. Musculoskeletal Disorders Drugs Market Competitive Landscape
18. Key Mergers And Acquisitions In The Musculoskeletal Disorders Drugs Market
19. Market Background: Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890207/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
